Knoop C et al. |
Tacrolimus pharmacokinetics and dose monitoring after lung transplantation for cystic fibrosis and other conditions. |
2005 |
Am. J. Transplant. |
pmid:15888057
|
Kandaswamy R et al. |
A prospective randomized trial of steroid-free maintenance regimens in kidney transplant recipients--an interim analysis. |
2005 |
Am. J. Transplant. |
pmid:15888064
|
Cosio FG and Larson TS |
Cardiovascular disease after transplantation: do we know all of the variables? |
2003 |
Am. J. Transplant. |
pmid:12859523
|
Krämer BK et al. |
Cardiovascular risk factors and estimated risk for CAD in a randomized trial comparing calcineurin inhibitors in renal transplantation. |
2003 |
Am. J. Transplant. |
pmid:12859533
|
Ciancio G et al. |
The use of daclizumab, tacrolimus and mycophenolate mofetil in african-american and Hispanic first renal transplant recipients. |
2003 |
Am. J. Transplant. |
pmid:12859538
|
Latran M |
Response to Klintmalm on the use of generic immunosuppression. |
2012 |
Am. J. Transplant. |
pmid:22176636
|
Ellis CL and Racusen LC |
Mild rise in creatinine six months post kidney transplant. |
2012 |
Am. J. Transplant. |
pmid:22845913
|
Xu H et al. |
The allo- and viral-specific immunosuppressive effect of belatacept, but not tacrolimus, attenuates with progressive T cell maturation. |
2014 |
Am. J. Transplant. |
pmid:24472192
|
Qazi Y et al. |
Efficacy and Safety of Everolimus Plus Low-Dose Tacrolimus Versus Mycophenolate Mofetil Plus Standard-Dose Tacrolimus in De Novo Renal Transplant Recipients: 12-Month Data. |
2017 |
Am. J. Transplant. |
pmid:27775865
|
Abdelmalek MF et al. |
Sirolimus conversion regimen versus continued calcineurin inhibitors in liver allograft recipients: a randomized trial. |
2012 |
Am. J. Transplant. |
pmid:22233522
|
Boudjema K et al. |
Reduced-dose tacrolimus with mycophenolate mofetil vs. standard-dose tacrolimus in liver transplantation: a randomized study. |
2011 |
Am. J. Transplant. |
pmid:21466650
|
Coghill AE et al. |
Immunosuppressive Medications and Squamous Cell Skin Carcinoma: Nested Case-Control Study Within the Skin Cancer after Organ Transplant (SCOT) Cohort. |
2016 |
Am. J. Transplant. |
pmid:26824445
|
Knechtle SJ |
Guidance for liver transplant immunosuppression. |
2011 |
Am. J. Transplant. |
pmid:21466652
|
Egli A et al. |
Renal failure five years after lung transplantation due to polyomavirus BK-associated nephropathy. |
2010 |
Am. J. Transplant. |
pmid:20840474
|
Saikali JA et al. |
Sirolimus may promote thrombotic microangiopathy. |
2003 |
Am. J. Transplant. |
pmid:12603218
|
Budde K et al. |
Novel once-daily extended-release tacrolimus (LCPT) versus twice-daily tacrolimus in de novo kidney transplants: one-year results of Phase III, double-blind, randomized trial. |
2014 |
Am. J. Transplant. |
pmid:25278376
|
Duncan FJ et al. |
Clinically relevant immunosuppressants influence UVB-induced tumor size through effects on inflammation and angiogenesis. |
2007 |
Am. J. Transplant. |
pmid:17941958
|
Silva HT et al. |
Planned randomized conversion from tacrolimus to sirolimus-based immunosuppressive regimen in de novo kidney transplant recipients. |
2013 |
Am. J. Transplant. |
pmid:24266969
|
Ricciardelli I et al. |
Rapid generation of EBV-specific cytotoxic T lymphocytes resistant to calcineurin inhibitors for adoptive immunotherapy. |
2013 |
Am. J. Transplant. |
pmid:24266973
|
Hu X et al. |
Chimeric Allografts Induced by Short-Term Treatment With Stem Cell-Mobilizing Agents Result in Long-Term Kidney Transplant Survival Without Immunosuppression: A Study in Rats. |
2016 |
Am. J. Transplant. |
pmid:26749344
|
Suszynski TM et al. |
Prospective randomized trial of maintenance immunosuppression with rapid discontinuation of prednisone in adult kidney transplantation. |
2013 |
Am. J. Transplant. |
pmid:23432755
|
Cameron AM et al. |
Chimeric Allografts Induced by Short-Term Treatment With Stem Cell Mobilizing Agents Result in Long-Term Kidney Transplant Survival Without Immunosuppression: II, Study in Miniature Swine. |
2016 |
Am. J. Transplant. |
pmid:26748958
|
O'Grady JG et al. |
Randomized controlled trial of tacrolimus versus microemulsified cyclosporin (TMC) in liver transplantation: poststudy surveillance to 3 years. |
2007 |
Am. J. Transplant. |
pmid:17109723
|
Böhmig GA et al. |
Immunoadsorption in severe C4d-positive acute kidney allograft rejection: a randomized controlled trial. |
2007 |
Am. J. Transplant. |
pmid:17109725
|
Ferguson R et al. |
Immunosuppression with belatacept-based, corticosteroid-avoiding regimens in de novo kidney transplant recipients. |
2011 |
Am. J. Transplant. |
pmid:21114656
|
McKenna G and Trotter JF |
Does early (CNI) conversion lead to eternal (renal) salvation? |
2010 |
Am. J. Transplant. |
pmid:20928938
|
Hirsch HH et al. |
Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study. |
2013 |
Am. J. Transplant. |
pmid:23137180
|
Naesens M et al. |
Tacrolimus exposure and evolution of renal allograft histology in the first year after transplantation. |
2007 |
Am. J. Transplant. |
pmid:17608835
|
Koefoed-Nielsen PB et al. |
Blood tacrolimus levels and calcineurin phosphatase activity early after renal transplantation. |
2002 |
Am. J. Transplant. |
pmid:12099520
|
Klintmalm GB |
Immunosuppression, generic drugs and the FDA. |
2011 |
Am. J. Transplant. |
pmid:21794082
|
Shihab FS et al. |
Effect of corticosteroid withdrawal on tacrolimus and mycophenolate mofetil exposure in a randomized multicenter study. |
2013 |
Am. J. Transplant. |
pmid:23167508
|
Forns X and Navasa M |
Cyclosporine A or tacrolimus for hepatitis C recurrence? An old debate. |
2011 |
Am. J. Transplant. |
pmid:21797970
|
Alloway RR et al. |
A randomized pharmacokinetic study of generic tacrolimus versus reference tacrolimus in kidney transplant recipients. |
2012 |
Am. J. Transplant. |
pmid:22759200
|
Wlodarczyk Z et al. |
Pharmacokinetics for once- versus twice-daily tacrolimus formulations in de novo kidney transplantation: a randomized, open-label trial. |
2009 |
Am. J. Transplant. |
pmid:19681813
|
Chisholm-Burns MA et al. |
Immunosuppressant therapy adherence and graft failure among pediatric renal transplant recipients. |
2009 |
Am. J. Transplant. |
pmid:19681814
|
Schold JD and Kaplan B |
AZA/tacrolimus is associated with similar outcomes as MMF/tacrolimus among renal transplant recipients. |
2009 |
Am. J. Transplant. |
pmid:19681827
|
Arnold R et al. |
Association between calcineurin inhibitor treatment and peripheral nerve dysfunction in renal transplant recipients. |
2013 |
Am. J. Transplant. |
pmid:23841745
|
Troppmann C et al. |
Impact of portal venous pancreas graft drainage on kidney graft outcome in simultaneous pancreas-kidney recipients reported to UNOS. |
2004 |
Am. J. Transplant. |
pmid:15023146
|
Willicombe M et al. |
Outcome of patients with preformed donor-specific antibodies following alemtuzumab induction and tacrolimus monotherapy. |
2011 |
Am. J. Transplant. |
pmid:21299828
|
Pirenne J et al. |
Tolerance of liver transplant patients to strenuous physical activity in high-altitude. |
2004 |
Am. J. Transplant. |
pmid:15023147
|
Heisel O et al. |
New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis. |
2004 |
Am. J. Transplant. |
pmid:15023151
|
Hardinger KL et al. |
Pharmacokinetics of tacrolimus in kidney transplant recipients: twice daily versus once daily dosing. |
2004 |
Am. J. Transplant. |
pmid:15023155
|
Suwelack B et al. |
Withdrawal of cyclosporine or tacrolimus after addition of mycophenolate mofetil in patients with chronic allograft nephropathy. |
2004 |
Am. J. Transplant. |
pmid:15023160
|
Vanrenterghem Y et al. |
Minimization of immunosuppressive therapy after renal transplantation: results of a randomized controlled trial. |
2005 |
Am. J. Transplant. |
pmid:15636615
|
Bryan CF et al. |
Long-term survival of kidneys transplanted from live A2 donors to O and B recipients. |
2007 |
Am. J. Transplant. |
pmid:17359511
|
Vincenti F et al. |
Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. |
2007 |
Am. J. Transplant. |
pmid:17359512
|
Busque S et al. |
Calcineurin-inhibitor-free immunosuppression based on the JAK inhibitor CP-690,550: a pilot study in de novo kidney allograft recipients. |
2009 |
Am. J. Transplant. |
pmid:19660021
|
Diaz-Siso JR et al. |
Initial experience of dual maintenance immunosuppression with steroid withdrawal in vascular composite tissue allotransplantation. |
2015 |
Am. J. Transplant. |
pmid:25777324
|
Cendales L et al. |
Tacrolimus to Belatacept Conversion Following Hand Transplantation: A Case Report. |
2015 |
Am. J. Transplant. |
pmid:25773260
|
Vanhove T et al. |
Determinants of the Magnitude of Interaction Between Tacrolimus and Voriconazole/Posaconazole in Solid Organ Recipients. |
2017 |
Am. J. Transplant. |
pmid:28224698
|
Klintmalm GB et al. |
Belatacept-based immunosuppression in de novo liver transplant recipients: 1-year experience from a phase II randomized study. |
2014 |
Am. J. Transplant. |
pmid:25041339
|
Jaksch P et al. |
Alemtuzumab in lung transplantation: an open-label, randomized, prospective single center study. |
2014 |
Am. J. Transplant. |
pmid:25039364
|
TruneÄŒka P et al. |
Renal Function in De Novo Liver Transplant Recipients Receiving Different Prolonged-Release Tacrolimus Regimens-The DIAMOND Study. |
2015 |
Am. J. Transplant. |
pmid:25707487
|
Adam R et al. |
Improved survival in liver transplant recipients receiving prolonged-release tacrolimus in the European Liver Transplant Registry. |
2015 |
Am. J. Transplant. |
pmid:25703527
|
Asrani SK and O'Leary JG |
Can one pill a day keep rejection away? |
2015 |
Am. J. Transplant. |
pmid:25703394
|
Bhorade SM et al. |
Comparison of three tacrolimus-based immunosuppressive regimens in lung transplantation. |
2003 |
Am. J. Transplant. |
pmid:14629288
|
Madeleine MM et al. |
HPV-related cancers after solid organ transplantation in the United States. |
2013 |
Am. J. Transplant. |
pmid:24119294
|
Oetting WS et al. |
Genomewide Association Study of Tacrolimus Concentrations in African American Kidney Transplant Recipients Identifies Multiple CYP3A5 Alleles. |
2016 |
Am. J. Transplant. |
pmid:26485092
|
De Simone P et al. |
Everolimus with reduced tacrolimus in liver transplantation. |
2013 |
Am. J. Transplant. |
pmid:23601137
|
Badri P et al. |
Pharmacokinetics and dose recommendations for cyclosporine and tacrolimus when coadministered with ABT-450, ombitasvir, and dasabuvir. |
2015 |
Am. J. Transplant. |
pmid:25708713
|
Shihab F et al. |
Association of Clinical Events With Everolimus Exposure in Kidney Transplant Patients Receiving Low Doses of Tacrolimus. |
2017 |
Am. J. Transplant. |
pmid:28141897
|
Chodoff L and Hamberg KJ |
Response to 'Different preparations of tacrolimus and medication errors'. |
2009 |
Am. J. Transplant. |
pmid:19392982
|
Cherukuri A et al. |
An analysis of lymphocyte phenotype after steroid avoidance with either alemtuzumab or basiliximab induction in renal transplantation. |
2012 |
Am. J. Transplant. |
pmid:22390816
|
Larson TS et al. |
Complete avoidance of calcineurin inhibitors in renal transplantation: a randomized trial comparing sirolimus and tacrolimus. |
2006 |
Am. J. Transplant. |
pmid:16468960
|
Vitko S et al. |
Tacrolimus combined with two different dosages of sirolimus in kidney transplantation: results of a multicenter study. |
2006 |
Am. J. Transplant. |
pmid:16468962
|
Barth RN et al. |
Vascularized bone marrow-based immunosuppression inhibits rejection of vascularized composite allografts in nonhuman primates. |
2011 |
Am. J. Transplant. |
pmid:21668624
|
Chen G et al. |
A synergistic effect between PG490-88 and tacrolimus prolongs renal allograft survival in monkeys. |
2006 |
Am. J. Transplant. |
pmid:16539628
|
Guirado L et al. |
Efficacy and safety of conversion from twice-daily to once-daily tacrolimus in a large cohort of stable kidney transplant recipients. |
2011 |
Am. J. Transplant. |
pmid:21668633
|
Flechner SM et al. |
The ORION study: comparison of two sirolimus-based regimens versus tacrolimus and mycophenolate mofetil in renal allograft recipients. |
2011 |
Am. J. Transplant. |
pmid:21668635
|
Budde K |
How to use mTOR inhibitors? The search goes on. |
2011 |
Am. J. Transplant. |
pmid:21668636
|
Carenco C et al. |
Tacrolimus and the risk of solid cancers after liver transplant: a dose effect relationship. |
2015 |
Am. J. Transplant. |
pmid:25648361
|
Maes BD et al. |
Differential effect of diarrhea on FK506 versus cyclosporine A trough levels and resultant prevention of allograft rejection in renal transplant recipients. |
2002 |
Am. J. Transplant. |
pmid:12484345
|
Heller T et al. |
Plasma concentrations of mycophenolic acid acyl glucuronide are not associated with diarrhea in renal transplant recipients. |
2007 |
Am. J. Transplant. |
pmid:17532750
|
Schrepfer S et al. |
Effect of inhaled tacrolimus on cellular and humoral rejection to prevent posttransplant obliterative airway disease. |
2007 |
Am. J. Transplant. |
pmid:17532751
|
Grenda R et al. |
A randomized trial to assess the impact of early steroid withdrawal on growth in pediatric renal transplantation: the TWIST study. |
2010 |
Am. J. Transplant. |
pmid:20420639
|
Knechtle SJ et al. |
Early and limited use of tacrolimus to avoid rejection in an alemtuzumab and sirolimus regimen for kidney transplantation: clinical results and immune monitoring. |
2009 |
Am. J. Transplant. |
pmid:19344431
|
Asberg A et al. |
Effects of the intensity of immunosuppressive therapy on outcome of treatment for CMV disease in organ transplant recipients. |
2010 |
Am. J. Transplant. |
pmid:20486914
|
Hautz T et al. |
Molecular markers and targeted therapy of skin rejection in composite tissue allotransplantation. |
2010 |
Am. J. Transplant. |
pmid:20353468
|
Silva HT et al. |
One-year results with extended-release tacrolimus/MMF, tacrolimus/MMF and cyclosporine/MMF in de novo kidney transplant recipients. |
2007 |
Am. J. Transplant. |
pmid:17217442
|
Grinyo JM et al. |
Pilot randomized study of early tacrolimus withdrawal from a regimen with sirolimus plus tacrolimus in kidney transplantation. |
2004 |
Am. J. Transplant. |
pmid:15268733
|
Schussler T et al. |
Severe hepatitis C infection in a renal transplant recipient following hepatitis C genotype mismatch transplant. |
2004 |
Am. J. Transplant. |
pmid:15268744
|
Nijhoff MF et al. |
Glycemic Stability Through Islet-After-Kidney Transplantation Using an Alemtuzumab-Based Induction Regimen and Long-Term Triple-Maintenance Immunosuppression. |
2016 |
Am. J. Transplant. |
pmid:26288226
|
Bunnapradist S et al. |
Conversion from twice-daily tacrolimus to once-daily extended release tacrolimus (LCPT): the phase III randomized MELT trial. |
2013 |
Am. J. Transplant. |
pmid:23279614
|
Ceschi A et al. |
Acute calcineurin inhibitor overdose: analysis of cases reported to a national poison center between 1995 and 2011. |
2013 |
Am. J. Transplant. |
pmid:23279718
|
Toso C et al. |
Sequential kidney/islet transplantation: efficacy and safety assessment of a steroid-free immunosuppression protocol. |
2006 |
Am. J. Transplant. |
pmid:16611343
|
Lacaille F et al. |
Severe dysimmune cytopenia in children treated with tacrolimus after organ transplantation. |
2006 |
Am. J. Transplant. |
pmid:16611346
|
Chamie K et al. |
The effect of sirolimus on prostate-specific antigen (PSA) levels in male renal transplant recipients without prostate cancer. |
2008 |
Am. J. Transplant. |
pmid:18853950
|
Lefaucheur C et al. |
Renal histopathological lesions after lung transplantation in patients with cystic fibrosis. |
2008 |
Am. J. Transplant. |
pmid:18671673
|
Pech T et al. |
Intestinal regeneration, residual function and immunological priming following rescue therapy after rat small bowel transplantation. |
2012 |
Am. J. Transplant. |
pmid:22974463
|
Kaplan B and Kirk AD |
Tacrolimus and sirolimus: when bad things happen to good drugs. |
2006 |
Am. J. Transplant. |
pmid:16827845
|
McAlister VC et al. |
Cyclosporin versus tacrolimus as primary immunosuppressant after liver transplantation: a meta-analysis. |
2006 |
Am. J. Transplant. |
pmid:16827858
|
Gallon L et al. |
Long-term renal allograft function on a tacrolimus-based, pred-free maintenance immunosuppression comparing sirolimus vs. MMF. |
2006 |
Am. J. Transplant. |
pmid:16827862
|
Grenda R et al. |
A prospective, randomized, multicenter trial of tacrolimus-based therapy with or without basiliximab in pediatric renal transplantation. |
2006 |
Am. J. Transplant. |
pmid:16827869
|
Haufroid V et al. |
CYP3A5 and ABCB1 polymorphisms and tacrolimus pharmacokinetics in renal transplant candidates: guidelines from an experimental study. |
2006 |
Am. J. Transplant. |
pmid:17049058
|
Lake JR et al. |
Addition of MMF to dual immunosuppression does not increase the risk of malignant short-term death after liver transplantation. |
2005 |
Am. J. Transplant. |
pmid:16303011
|
Pallet N et al. |
Long-Term Clinical Impact of Adaptation of Initial Tacrolimus Dosing to CYP3A5 Genotype. |
2016 |
Am. J. Transplant. |
pmid:26990694
|
Barbas AS et al. |
Posterior reversible encephalopathy syndrome independently associated with tacrolimus and sirolimus after multivisceral transplantation. |
2013 |
Am. J. Transplant. |
pmid:23331705
|
Fujishiro J et al. |
Influence of immunosuppression on alloresponse, inflammation and contractile function of graft after intestinal transplantation. |
2010 |
Am. J. Transplant. |
pmid:20642681
|
Martinez F et al. |
High dose epoetin beta in the first weeks following renal transplantation and delayed graft function: Results of the Neo-PDGF Study. |
2010 |
Am. J. Transplant. |
pmid:20642691
|
Mandelbrot DA et al. |
Effect of Ramipril on Urinary Protein Excretion in Maintenance Renal Transplant Patients Converted to Sirolimus. |
2015 |
Am. J. Transplant. |
pmid:26176342
|